Usage of deoxyspergualin on steroid-resistant acute rejection in living donor liver transplantation

Tohoku Journal of Experimental Medicine

Volumn 208, Issue 3, 2006, Pages 225-233

  Kawagishi, Naoki ^a   Satoh, Kazushige ^a   Enomoto, Yoshitaka ^a   Akamatsu, Yorihiro ^a   Sekiguchi, Satoshi ^a   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO incompatibility; Deoxyspergualin (DSG); Liver transplantation; Living donor; Rejection

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; TSUKUBAENOLIDE;

ACUTE GRAFT REJECTION; ADULT; APHERESIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SUBSTITUTION; FEMALE; HUMAN; LEUKOPENIA; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRANULOCYTE COLONY-STIMULATING FACTOR; GUANIDINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LEUKOPENIA; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644500810     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.208.225     Document Type: Article

References (21)

1. Amemiya, H., Suzuki, S., Ota, K., Takahashi, K., Sonoda, T., Ishibashi, M., Omoto, R., Koyama, I., Dohi, K., Fukuda, Y. & Fukao, K. (1990) A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients. Transplantation, 49, 337-343.
2. Donaldson, P.T., Thomson, L.J., Heads, A., Underhill, J.A., Vaughan, R.W., Rolando, N. & Williams, R. (1995) IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry: Transplantation, 60, 1016-1023.
3. Ernst, C., Thurin, J., Atkinson, B., Wurzel, H., Herlyn, M., Stromberg, N., Civin, C. & Koprowski, H. (1984) Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am. J. Pathol., 117, 451-461.
4. Farges, O., Kalil, A.N., Samuel, D., Saliba, F., Arulnaden, J.L., Debat, P., Bismuth, A., Castaing, D. & Bismuth, H. (1995) The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation, 59, 1124-1133.
5. Fujii, H., Takata, T., Nemoto, K., Yamashita, T., Abe, F., Fujii, A. & Takeuchi, T. (1990) Deoxyspergualin directly suppress antibody formation in vivo and in vitro. J. Antibiotics, 43, 213-219.
6. Groth, C.G., Ohlman, S., Ericzon, B.G., Barkholt, L. & Reinholt, F.P. (1990) Deoxyspergualin for liver graft rejection. Lancet, 336, 626.
7. International Working Party (1995) Terminology for hepatic allograft rejection. Hepatology, 22, 648-654.
8. Kato, H., Ohkohchi, N., Orii, T. Doi, H. & Satomi, S. (1997) Effectiveness of 15-deoxyspergualin on steroid-resistant acute rejection in living related liver transplantation. Transplant. Proc., 29, 553-554.
9. Kawagishi, N., Ohkohchi, N., Fujimori, K., Orii, T., Chubachi, S., Koyamada, N., Watanabe, M., Asakura, T., Gotoh, M. & Satomi, S. (2001a) Experience with artificial liver support in 16 living related liver transplant recipients. Therapeutic Apheresis, 5, 7-11.
10. Kawagishi, N., Ohkohchi, N., Fujimori, K., Orii, T., Kikuchi, H., Koyamada, N., Sekiguchi, S., Tsukamoto, S., Sato, S. & Satomi, S. (2001b) Antibody elimination with living donor liver transplantation. Therapeutic Apheresis, 5, 449-454.
11. Kenmochi, K., Suzuki, S., Hayashi, R., Fukuoka, T. & Amemiya, H. (1990) Immunosuppressive effect of 15-deoxyspergualin on acute rejection after clinical renal transplantation. Isyoku, 25, 618-623.
12. Manez, R., Kelly, R.H., Kobayashi, M., Takaya, S., Bronsther, O., Kramer, D., Duquesnoy, R.J., Iwaki, Y., Fung, J.J. & Starzl, T.E. (1995) Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology, 21, 1345-1352.
13. Nadler, S.G., Tepper, M.A., Schacter, B. & Mazzucco, C.E. (1992) Interaction of the immunosuppressant deoxyspergualin with a number of the Hsp7O family of heart shock proteins. Science, 258, 484-486.
14. Nemoto, K., Abe, F., Nakamura, T., Ishizuka, M., Takeuchi, T. & Umezawa, H. (1987) Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J. Antibiotics, 40, 1062-1064.
15. Nemoto, K., Hayashi, M., Abe, T., Nakamura, T., Ishizuka, M. & Umezawa, H. (1987) Immunosuppressive activities of 15-deoxyspergualin in animals. J. Antibiotics, 40, 1303-1310.
16. Ohkubo, M., Tamura, K., Kamata, K., Tsukamoto, Y., Nakayama, Y., Osakabe, T., Sato, K., Go, M., Kumano, K. & Endo, T. (1993) 15-Deoxyspergualin "rescue therapy" for methylprednisolone-resistant rejection of renal transplantas as compared with anti-T cell monoclonal antibody (OKT3). Transplantation, 55, 505-508.
17. Okazaki, H., Takahashi, H., Jimbo, M., Iguro, T., Satoh, T. & Ishizak, M. (1989) Transplant outcome with donor specific buffy-coat and lymphocyte-transfused patients. Transplant. Proc., 21, 1832-1833.
18. Okazaki, H., Sato, T., Jimbo, M., Senga, S., Amada, N. & Oguma, S. (1991) Prophylactic use of deoxyspergualin in living related renal transplantation. Transplant. Proc., 23, 1094-1095.
19. Takahashi, K., Yagisawa, T., Sonda, K., Kawaguchi, H., Yamaguchi, Y., Toma, H., Agishi, T. & Ota, K. (1993) ABO-incompatible kidney transplantation in a single-center trial. Transplant. Proc., 25, 271-273.
20. Takeuchi, T., Iimura, H., Kunimoto, S., Masuda, T., Ishizuka, M., Takeuchi, M., Hamada, M., Naganawa, H., Kondo, S. & Umezawa, H. (1981) A new antitumor antibiotic spergualin: Isolation and antitumor activity. J. Antibiotics, 34, 1619-1621.
21. Wahoff, D., Papalois. B., Leone, J., Aasheim, T., Gilmore, T. & Sutherland, D.E. (1996) The effect of 15-deoxyspergualin on islet allograft survival in the canine model. Transplant. Proc., 28, 912.